• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.早产儿万古霉素持续静脉滴注:一种新的给药方案。
Br J Clin Pharmacol. 1998 Aug;46(2):163-7. doi: 10.1046/j.1365-2125.1998.00763.x.
2
Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.新生儿和婴儿的万古霉素药代动力学:一项回顾性评估。
Ann Pharmacother. 1993 Apr;27(4):490-6. doi: 10.1177/106002809302700417.
3
Vancomycin pharmacokinetics and dosing in premature neonates.万古霉素在早产儿中的药代动力学及给药剂量
Ther Drug Monit. 1995 Aug;17(4):319-26. doi: 10.1097/00007691-199508000-00001.
4
Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.持续输注万古霉素治疗疑似或确诊革兰氏阳性感染的早产儿:一种新的给药方案。
Arch Dis Child Fetal Neonatal Ed. 2008 Nov;93(6):F418-21. doi: 10.1136/adc.2007.128280. Epub 2008 May 1.
5
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.对疑似或确诊革兰氏阳性感染患者采用常规给药与万古霉素持续输注疗法的比较。
Antimicrob Agents Chemother. 1996 Mar;40(3):696-700. doi: 10.1128/AAC.40.3.696.
6
Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.万古霉素间歇输注与持续输注给药对耐甲氧西林金黄色葡萄球菌和粪肠球菌杀菌活性的比较
Pharmacotherapy. 1998 Sep-Oct;18(5):1069-74.
7
Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.连续性静脉滴注万古霉素在接受连续性肾脏替代治疗的脓毒症患者中的应用。
Int J Antimicrob Agents. 2013 Mar;41(3):261-6. doi: 10.1016/j.ijantimicag.2012.10.018. Epub 2013 Jan 9.
8
Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.万古霉素在新生儿中的持续输注:剂量优化和治疗药物监测。
Arch Dis Child. 2013 Jun;98(6):449-53. doi: 10.1136/archdischild-2012-302765. Epub 2012 Dec 19.
9
Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.早产儿人群药代动力学研究:万古霉素在马来西亚早产儿中的药代动力学研究:确定剂量的预测因子。
Antimicrob Agents Chemother. 2010 Jun;54(6):2626-32. doi: 10.1128/AAC.01370-09. Epub 2010 Apr 12.
10
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.优化剂量方案与万古霉素标准剂量方案治疗 90 天以下新生儿和婴儿革兰阳性微生物引起的晚发性败血症(NeoVanc):一项随机对照试验研究方案。
Trials. 2020 Apr 15;21(1):329. doi: 10.1186/s13063-020-4184-8.

引用本文的文献

1
Predictive Performance of Pharmacokinetic Model-Based Virtual Trials of Vancomycin in Neonates: Mathematics Matches Clinical Observation.基于药代动力学模型的新生儿万古霉素虚拟试验的预测性能:数学与临床观察相符。
Clin Pharmacokinet. 2022 Jul;61(7):1027-1038. doi: 10.1007/s40262-022-01128-z. Epub 2022 May 6.
2
Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes.万古霉素剂量优化方案在新生儿中的实施:对万古霉素暴露、生物学参数和临床结局的影响。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0219121. doi: 10.1128/aac.02191-21. Epub 2022 Apr 25.
3
Target Attainment and Clinical Efficacy for Vancomycin in Neonates: Systematic Review.万古霉素在新生儿中的目标达成情况及临床疗效:系统评价
Antibiotics (Basel). 2021 Mar 25;10(4):347. doi: 10.3390/antibiotics10040347.
4
Continuous Infusion Vancomycin in Pediatric Patients: A Critical Review of the Evidence.儿科患者万古霉素持续输注:证据的批判性综述
J Pediatr Pharmacol Ther. 2020;25(3):198-214. doi: 10.5863/1551-6776-25.3.198.
5
Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal.新生儿持续输注万古霉素:给药方案评估与治疗建议
Front Pediatr. 2019 May 14;7:188. doi: 10.3389/fped.2019.00188. eCollection 2019.
6
Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.持续输注万古霉素以提高婴幼儿万古霉素目标血药浓度的随机对照试验方案:VANC试验
BMJ Open. 2018 Nov 3;8(11):e022603. doi: 10.1136/bmjopen-2018-022603.
7
Optimizing the Use of Antibacterial Agents in the Neonatal Period.优化新生儿期抗菌药物的使用
Paediatr Drugs. 2016 Apr;18(2):109-22. doi: 10.1007/s40272-015-0161-1.
8
Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.基于群体药代动力学模型的新生儿及婴儿万古霉素合理给药算法研究
Antimicrob Agents Chemother. 2015 Dec 7;60(2):1013-21. doi: 10.1128/AAC.01968-15. Print 2016 Feb.
9
Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.新生儿和婴儿最常用的抗菌药、抗真菌药和抗病毒药的药代动力学和药效学
Clin Pharmacokinet. 2014 Jul;53(7):581-610. doi: 10.1007/s40262-014-0147-0.
10
Optimization of vancomycin dosing in very low-birth-weight preterm neonates.极低出生体重早产儿万古霉素给药方案的优化
Am J Perinatol. 2015 Jan;32(1):83-6. doi: 10.1055/s-0034-1376183. Epub 2014 May 16.

本文引用的文献

1
INTRAUTERINE GROWTH AS ESTIMATED FROM LIVEBORN BIRTH-WEIGHT DATA AT 24 TO 42 WEEKS OF GESTATION.根据孕24至42周活产儿出生体重数据估算的宫内生长情况。
Pediatrics. 1963 Nov;32:793-800.
2
Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.新生儿和婴儿的万古霉素药代动力学:一项回顾性评估。
Ann Pharmacother. 1993 Apr;27(4):490-6. doi: 10.1177/106002809302700417.
3
Vancomycin-associated shock in neonates.
Pediatr Infect Dis J. 1993 Jan;12(1):104-5. doi: 10.1097/00006454-199301000-00026.
4
Vancomycin therapeutic drug monitoring: is it necessary?万古霉素治疗药物监测:有必要吗?
Ann Pharmacother. 1993 May;27(5):594-8. doi: 10.1177/106002809302700514.
5
Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years.10年间新生儿重症监护病房表皮葡萄球菌血流感染分离株的地方性医院内传播
J Infect Dis. 1994 Mar;169(3):526-31. doi: 10.1093/infdis/169.3.526.
6
Outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit.新生儿重症监护病房耐甲氧西林金黄色葡萄球菌暴发
J Hosp Infect. 1993 Mar;23(3):211-22. doi: 10.1016/0195-6701(93)90026-v.
7
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.环丙沙星、氧氟沙星、头孢唑林和万古霉素在葡萄球菌伤口感染实验模型中的比较预防效果。
Antimicrob Agents Chemother. 1994 Jun;38(6):1325-30. doi: 10.1128/AAC.38.6.1325.
8
Vancomycin toxicity. What is the evidence for dose dependency?
Adverse Drug React Toxicol Rev. 1994 Summer;13(2):103-14.
9
[Continuous infusion of vancomycin during the neonatal period].
Pathol Biol (Paris). 1994 May;42(5):525-9.
10
Clinical pharmacology and efficacy of vancomycin in pediatric patients.
J Pediatr. 1980 Jan;96(1):119-26. doi: 10.1016/s0022-3476(80)80347-7.

早产儿万古霉素持续静脉滴注:一种新的给药方案。

Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.

作者信息

Pawlotsky F, Thomas A, Kergueris M F, Debillon T, Roze J C

机构信息

Unité de Réanimation Néonatologie, Hôpital Mère et Enfant, CHU Nantes, France.

出版信息

Br J Clin Pharmacol. 1998 Aug;46(2):163-7. doi: 10.1046/j.1365-2125.1998.00763.x.

DOI:10.1046/j.1365-2125.1998.00763.x
PMID:9723826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1873667/
Abstract

AIMS

Since vancomycin's bactericidal action has been shown to be time-dependent, a constant rate infusion over 24 h might result in a better bactericidal efficacy. The purpose of this study was to define a new dosage schedule in prematures.

METHODS

Two vancomycin 24 h constant rate infusion schedules were tested in two groups of neonates. Postconceptional age (PCA) was 27 to 41 weeks in group 1 (n=24) and 28 to 51.5 weeks in group 2 (n=29). Group 1 neonates received continuous infusion of 10 to 30 mgkg(-1) day(-1), adjusted for PCA and weight. Group 2 was designed to take into account the significant relationship observed in group 1 between vancomycin clearance standardized on weight and PCA and consisted of a constant loading dose of 7 mg kg(-1) followed by continuous infusion of 10 to 40 mg kg(-1) day(-1) adjusted for PCA and weight.

RESULTS

Mean vancomycin serum concentration at steady state was 11+/-3.1 mg1(-1) in group 1 and 15.4+/-6.2 mg1(-1) in group 2. Fifty-six percent of group 1 values vs 88% of group 2 values were between 10 and 30 mg at steady state (P<0.01). Both regimens were well tolerated.

CONCLUSIONS

A loading dose of vancomycin followed by constant rate infusion of the appropriate dose adjusted for PCA and weight might improve vancomycin concentrations in neonates.

摘要

目的

由于已证明万古霉素的杀菌作用具有时间依赖性,24小时持续静脉滴注可能会产生更好的杀菌效果。本研究的目的是确定一种针对早产儿的新给药方案。

方法

在两组新生儿中测试了两种万古霉素24小时持续静脉滴注方案。第1组(n = 24)的孕龄(PCA)为27至41周,第2组(n = 29)为28至51.5周。第1组新生儿接受10至30mgkg(-1)天(-1)的持续静脉滴注,并根据PCA和体重进行调整。第2组的设计考虑了在第1组中观察到的万古霉素清除率与体重和PCA之间的显著关系,包括7mg kg(-1)的恒定负荷剂量,随后是10至40mg kg(-1)天(-1)的持续静脉滴注,并根据PCA和体重进行调整。

结果

第1组稳态时万古霉素的平均血清浓度为11±3.1mg1(-1),第2组为15.4±6.2mg1(-1)。稳态时第1组56%的值与第2组88%的值在10至30mg之间(P<0.01)。两种方案耐受性均良好。

结论

先给予万古霉素负荷剂量,然后根据PCA和体重调整合适剂量进行持续静脉滴注,可能会提高新生儿体内的万古霉素浓度。